Cite

HARVARD Citation

    Jouenne, F. et al. (2017). Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma. Journal of medical genetics. 54 (9), pp. 607-612. [Online]. 
  
Back to record